Kay Kwok Ng
Corporate Officer/Principal bei CPA Australia Ltd.
Profil
Kay Kwok Ng is a Member at CPA Australia Ltd.
He previously held positions as Chief Executive Officer & Executive Director at GET Holdings Ltd.
from 2010 to 2013, Non-Executive Director at Everpride Biopharmaceutical Co. Ltd.
from 2006 to 2010, Independent Non-Executive Director at CCIAM Future Energy Ltd.
from 2018 to 2020, Independent Non-Executive Director at GoFintech Innovation Ltd.
from 2007 to 2019, and Independent Non-Executive Director at NOIZ Group Ltd.
from 2013 to 2019.
He obtained his undergraduate degree from Australian National University and Macquarie University.
Currently, Mr. Ng is a Member at CPA Australia Ltd.
Aktive Positionen von Kay Kwok Ng
| Unternehmen | Position | Beginn |
|---|---|---|
CPA Australia Ltd.
 CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Corporate Officer/Principal | 29.03.2010 |
Ehemalige bekannte Positionen von Kay Kwok Ng
| Unternehmen | Position | Ende |
|---|---|---|
| CCIAM FUTURE ENERGY LIMITED | Direktor/Vorstandsmitglied | 01.09.2020 |
| GOFINTECH INNOVATION LIMITED | Direktor/Vorstandsmitglied | 13.12.2019 |
| NOIZ GROUP LIMITED | Direktor/Vorstandsmitglied | 01.04.2019 |
| GET HOLDINGS LIMITED | Vorstandsvorsitzender | 24.05.2013 |
Everpride Biopharmaceutical Co. Ltd.
 Everpride Biopharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Everpride Biopharmaceutical Co. Ltd. principal activities are manufacturing and selling of medicines known as 'Plasmin Capsule' and 'Puli Capsule'. Plasmin capsule has the principal effect of resolving blood clots and may be used for treatment of cardiovascular diseases. Puli capsule has the principal effect of treating osteoarthritis. Other activity includes investment holding. Operations are carried out in the People's Republic of China. Everpride Biopharmaceutical Co. Ltd. was incorporated in the Cayman Islands on 1 August 2000 | Direktor/Vorstandsmitglied | 22.04.2010 |
Ausbildung von Kay Kwok Ng
| Australian National University | Undergraduate Degree |
| Macquarie University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| GOFINTECH INNOVATION LIMITED | Finance |
| GET HOLDINGS LIMITED | Technology Services |
| NOIZ GROUP LIMITED | Finance |
| CCIAM FUTURE ENERGY LIMITED | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
CPA Australia Ltd.
CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Commercial Services |
Everpride Biopharmaceutical Co. Ltd.
Everpride Biopharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Everpride Biopharmaceutical Co. Ltd. principal activities are manufacturing and selling of medicines known as 'Plasmin Capsule' and 'Puli Capsule'. Plasmin capsule has the principal effect of resolving blood clots and may be used for treatment of cardiovascular diseases. Puli capsule has the principal effect of treating osteoarthritis. Other activity includes investment holding. Operations are carried out in the People's Republic of China. Everpride Biopharmaceutical Co. Ltd. was incorporated in the Cayman Islands on 1 August 2000 | Health Technology |
